Akram N. Ibraheem-Al

Queen Rania Al Abdullah Street
Amman, AM 11941, Jordan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 216 publications

PET/CT in acute and time-sensitive non-oncological conditions: Current evidence, clinical applications, and emerging roles.

PET/CT in acute and time-sensitive non-oncological conditions: Current evidence, clinical applications, and emerging roles.

Journal: Seminars in nuclear medicine

Published: August 12, 2026

Radiation dose optimization and dosimetry in pediatric nuclear medicine: Current concepts and future directions.

Radiation dose optimization and dosimetry in pediatric nuclear medicine: Current concepts and future directions.

Journal: Seminars in nuclear medicine

Published: July 09, 2026

Uneven Global Distribution of Theranostics.

Uneven Global Distribution of Theranostics.

Journal: World journal of nuclear medicine

Published: July 03, 2026

68Ga-FAPI Avidity in Fat Necrosis and Adrenal Adenoma: Expanding the Spectrum of Benign Pitfalls in Oncologic Imaging.

68Ga-FAPI Avidity in Fat Necrosis and Adrenal Adenoma: Expanding the Spectrum of Benign Pitfalls in Oncologic Imaging.

Journal: Molecular imaging and radionuclide therapy

Published: June 23, 2026

PET Imaging in Vulvar Cancer: A Literature Review of the Current Evidence and Clinical Applications.

PET Imaging in Vulvar Cancer: A Literature Review of the Current Evidence and Clinical Applications.

Journal: Cancers

Published: May 31, 2026

Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

Prevalence of PD-L1 Expression in Non-Small Cell Lung Cancer: A Real-World Analysis From Jordan.

Journal: JCO global oncology

Published: May 29, 2026

Imaging Immunotherapy.

Imaging Immunotherapy.

Journal: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

Published: May 21, 2026

Is There an Added Value of Dual-Time-Point [68Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings?

Is There an Added Value of Dual-Time-Point [68Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) PET/CT in Differentiating Malignant and Benign Uptake Findings?

Journal: Cancers

Published: May 07, 2026

Fibroblast Activation Protein-Targeted Radioligand Therapy (FAP RLT) in Gastroenteropancreatic Malignancies: Biological Rationale, Clinical Evidence, and Future Directions.

Fibroblast Activation Protein-Targeted Radioligand Therapy (FAP RLT) in Gastroenteropancreatic Malignancies: Biological Rationale, Clinical Evidence, and Future Directions.

Journal: World journal of nuclear medicine

Published: May 04, 2026

WJNM with WARMTH: A Driving Force in Promoting Global Nuclear Medicine.

WJNM with WARMTH: A Driving Force in Promoting Global Nuclear Medicine.

Journal: World journal of nuclear medicine

Published: May 04, 2026

PET/CT Identifies Pubic Melorheostosis with High 68Ga-PSMA Uptake in a Patient with Prostate Cancer.

PET/CT Identifies Pubic Melorheostosis with High 68Ga-PSMA Uptake in a Patient with Prostate Cancer.

Journal: Molecular imaging and radionuclide therapy

Published: April 28, 2026

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

Journal: Thyroid : official journal of the American Thyroid Association

Published: April 13, 2026

Showing 1-12 of 216

Last Updated: 09/26/2026